CD8A and triple-negative breast carcinoma: Liu et al.29 primarily explored the potential role of APOE+ macrophage in ICB therapy among pan-cancer analysis, and the infiltration might be related CD8+T exhausted cells and to ICB therapy failure in triple negative breast cancer (TNBC).